Press Releases

2017  |  2016  |  2015  |  2014  |  2013

SSON Analytics launches benchmarking study with top 20 most admired shared services organisations globally

BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics

BD Statement on Appointment of Dr. John Nkengasong as First Director of Africa Centers for Disease Control

BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System

2016 Analyst Day Presentations

BD Announces 2016 Analyst Day and Webcast

BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery

BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin

BD Announces Results for 2016 Fourth Fiscal Quarter and Full Year

BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections

BD and Apax Partners Announce Closing of Joint Venture to Launch Global Respiratory Business

BD Expands Efforts to Combat Antimicrobial Resistance with New Automated ID/AST System

BD Receives FDA 510(k) Clearance for Innovative Next Generation Blood Collection and Separation Technology Designed to Improve Laboratory Efficiency

BD Invests $100 Million in Nebraska Plant to Expand Insulin Syringe Manufacturing

BD Unveils Next Generation Wireless Point-of-Care Diagnostic Device

BD and Vancive Medical Technologies Launch New Vascular Dressings with CHG Antimicrobial

BD Expands Portfolio of Reproductive and Sexually Transmitted Infections Solutions

BD Announces New Software Release for Pyxis Enterprise Solution

BD Submits Pre-Market Approval Application to FDA for BD Onclarity™ HPV Test

Mayo Clinic Proceedings Publishes New Insulin Injection and Infusion Recommendations

BD Cited as Infusion Pump EMR Integration Leader in Klas Report

BD Receives FDA Clearance for New Syringe Designed for the Administration of Humulin® R U-500 Insulin

BD Announces Results for 2016 Third Fiscal Quarter

BD Names R. Andrew Eckert To Board Of Directors

BD Board Declares Dividend

BD Hits Century Mark with Infusion Pump Interoperability

BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

BD and Check-Points Announce Development and Global Distribution Agreement for BD MAX™ Assays that Detect Carbapenem—resistant Organisms

BD Expands its Portfolio of Easy-to-Use Cell Sorters with Introduction of BD FACSMelody™ System

BD Expands Reproductive and Sexually Transmitted Infections Portfolio with CE Mark for the BD MAX™ Vaginal Panel

BD Announces Results for 2016 Second Fiscal Quarter

BD Extends Longstanding Expertise in Diabetes Management to Benefit Pets

BD Introduces New Low-Temperature Sterilization Containers

BD Divests Vertebral Augmentation Solutions Business to Stryker

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ PEDS Plus™/F Plastic Bottle

MedMined® Surveillance Advisor Wins 2015/2016 KLAS Category Leader Award

BD, Apax Partners to Form Joint Venture for Respiratory Solutions

BD Receives FDA Approval for New Automated Cervical Cancer Screening System

BD Utilizes AT&T Connectivity to Offer Connected Wireless Health Devices

BD Receives CE Mark for Next Generation Blood Separation Technology

Alaris™ System Named 2015 Best In KLAS for Smart Pumps

BD Receives FDA 510(k) Clearance for New Blood Collection Device to Help Enhance Patient and Clinician Experience

BD Unveils New Next Generation Sequencing Library Prep System at the 2016 Advances in Genome Biology and Technology Meeting

BD Launches BD FACSymphony™ High-Speed Cell Analyzer to Enable Identification and Analysis of Rare Cell Types

BD Licenses Technology to Advance Testing for Preeclampsia, Gestational Diabetes

BD Announces Results for 2016 First Fiscal Quarter

BD Board Declares Dividend

Singularity University and BD Announce Collaboration Dedicated to Address Global Healthcare Challenges

BD Announces Webcast of Annual Meeting of Shareholders

Fresenius Kabi USA Acquires U.S. Pharmaceutical Plant and Ready to Administer Drugs from BD

BD Divests BD RX Business, Adding IV Solutions

BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call

BD to Present at the 34th Annual J. P. Morgan Healthcare Conference